SGCA
AMPE

Steel Grove Capital Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Steel Grove Capital Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-185
Closed -$32K – 133
2019
Q4 		$32K Hold
185
– – 0.02% 120
2019
Q3 		$28K Hold
185
– – 0.02% 115
2019
Q2 		$22K Hold
185
– – 0.01% 115
2019
Q1 		$31K Hold
185
– – 0.02% 117
2018
Q4 		$22K Buy
+185
New +$28.4K ﹤0.01% 310

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
HC
HNP Capital Rochester, New York $359M AUM 3.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Steel Grove Capital Advisors's AMPE Position: Q1 2020 in Review

Steel Grove Capital Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2020, closing a stake of 185 shares — an estimated $32K sold.

Steel Grove Capital Advisors first reported a position in AMPE in Q4 2018 and held it in 5 quarters. The position peaked at $32K in Q4 2019. 77 funds tracked by Wall St. Rank hold AMPE as of Q1 2020.

  • Steel Grove Capital Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2020 after selling out during the quarter.
  • Steel Grove Capital Advisors sold 185 Ampio Pharmaceuticals Inc. shares in Q1 2020, an estimated $32K.
  • Steel Grove Capital Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 5 quarters.
  • Steel Grove Capital Advisors's Ampio Pharmaceuticals Inc. position peaked at $32K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2020.

Based on Steel Grove Capital Advisors's 13F filing for Q1 2020, filed 15 May 2020.